Literature DB >> 7548571

Recurrent Clostridium difficile infection in a patient with selective IgG1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii.

J Hassett1, S Meyers, L McFarland, M E Mulligan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7548571     DOI： 10.1093/clinids/20.supplement_2.s266

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

Review 2.  Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review.

Authors:  Marwan S Abougergi; John H Kwon
Journal:  Dig Dis Sci       Date:  2010-10-06       Impact factor: 3.199

Review 3.  Passive immunity in prevention and treatment of infectious diseases.

Authors:  M A Keller; E R Stiehm
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 4.  Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies.

Authors:  Lauren E Hudson; Sarah E Anderson; Anita H Corbett; Tracey J Lamb
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

5.  Intravenous immunoglobulin therapy for severe Clostridium difficile colitis.

Authors:  J Salcedo; S Keates; C Pothoulakis; M Warny; I Castagliuolo; J T LaMont; C P Kelly
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

Review 6.  Treatment of recurrent Clostridium difficile infection: a systematic review.

Authors:  J C O'Horo; K Jindai; B Kunzer; N Safdar
Journal:  Infection       Date:  2013-07-10       Impact factor: 3.553

7.  Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.

Authors:  A Qamar; S Aboudola; M Warny; P Michetti; C Pothoulakis; J T LaMont; C P Kelly
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

8.  Recurrent C. difficile in a Patient with IgG Deficiency.

Authors:  Asad Jehangir; Kyle Bennett; Shoaib Bilal Fareedy; Andrew Rettew; Bilal Shaikh; Anam Qureshi; Qasim Jehangir; Richard Alweis
Journal:  Case Rep Gastrointest Med       Date:  2015-04-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.